US FDA chief says rapidly working to issue Moderna vaccine authorization - world news hindustantimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hindustantimes.com Daily Mail and Mail on Sunday newspapers.
The US Food and Drug Administration s advisory panel, comprising external experts, has given an emergency use approval to Moderna COVID-19 vaccine, making it the second drug after Pfizer to receive such an authorisation in less than a week. FDA s Vaccines and Related Biological Products Advisory Committee (VRBPAC), made up of independent scientific and public health experts, at its meeting on Thursday voted 20-0 with one abstention to recommend Emergency Use Authorization for the Moderna COVID-19 vaccine mRNA-1273. The FDA on Friday allowed the emergency use of the country s first COVID-19 vaccine developed by American pharmaceutical giant Pfizer and its German partner BioNTech to combat the disease that has killed over 310,000 people in the country.
File Photo
WASHINGTON: The US Food and Drug Administration s advisory panel, comprising external experts, has given an emergency use approval to Moderna Covid-19 vaccine, making it the second drug after Pfizer to receive such an authorisation in less than a week.
FDA s Vaccines and Related Biological Products Advisory Committee (VRBPAC), made up of independent scientific and public health experts, at its meeting on Thursday voted 20-0 with one abstention to recommend Emergency Use Authorization for the Moderna Covid-19 vaccine mRNA-1273.
The FDA on Friday allowed the emergency use of the country s first Covid-19 vaccine developed by American pharmaceutical giant Pfizer and its German partner BioNTech to combat the disease that has killed over 310,000 people in the country.
FDA Advisors Recommend Emergency Use Authorisation of Moderna COVID-19 Vaccine
FDA s Vaccines and Related Biological Products Advisory Committee made up of independent scientific and public health experts voted 20-0 with one abstention to recommend emergency use authorisation.
A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020. Photo: REUTERS/Brian Snyder
World18/Dec/2020
Washington: The US Food and Drug Administration’s advisory panel, comprising external experts, has given an emergency use approval to Moderna COVID-19 vaccine, making it the second drug after Pfizer to receive such an authorisation in less than a week.